An amendment to prohibit the use of funds from being available for the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services (ITAC 3) unless the membership of the committee is "fairly balanced in terms of the points of view represented" pursuant to section 5(b)(2) of the Federal Advisory Committee Act; or the Industry Trade Advisory Committee on Intellectual Property Rights (ITAC 15) unless the membership of the committee is "fairly balanced in terms of the points of view represented" pursuant to section 5(b)(2) of the Federal Advisory Committee Act.
What it does: Adds TITLE VIII--ADDITIONAL GENERAL PROVISIONS at the end of the bill
Rep. Henry A. Waxman (D-CA)Description
Amendment prohibits funds in the bill from being used for-- (1) the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services, or (2) the Industry Trade Advisory Committee on Intellectual Property Rights unless certain membership requirements are met.
What it changes
1 change to H.R. 5672
We couldn't match these changes to the text of H.R. 5672, so they're shown as written.
Adds TITLE VIII--ADDITIONAL GENERAL PROVISIONS at the end of the bill
Adds a titleInserted: TITLE VIII--ADDITIONAL GENERAL PROVISIONS
Inserted: Sec. 801. None of the funds made available in this Act may be used for--
Inserted: (1) the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services (ITAC 3) unless the membership of the committee is "fairly balanced in terms of the points of view represented" pursuant to section 5(b)(2) of the Federal Advisory Committee Act (5. U.S. App.); or
Inserted: (2) the Industry Trade Advisory Committee on Intellectual Property Rights (ITAC 15) unless the membership of the committee is "fairly balanced in terms of the points of view represented" pursuant to section 5(b)(2) of the Federal Advisory Committee Act.
Original wording
At the end of the bill (before the short title), insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
At the end of the bill (before the short title), insert the following:
TITLE VIII--ADDITIONAL GENERAL PROVISIONS
Sec. 801. None of the funds made available in this Act may be used for--
(1) the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services (ITAC 3) unless the membership of the committee is “fairly balanced in terms of the points of view represented” pursuant to section 5(b)(2) of the Federal Advisory Committee Act (5. U.S. App.); or
(2) the Industry Trade Advisory Committee on Intellectual Property Rights (ITAC 15) unless the membership of the committee is “fairly balanced in terms of the points of view represented” pursuant to section 5(b)(2) of the Federal Advisory Committee Act.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
House amendment offered
June 28, 2006
View full timeline
House amendment offered
June 28, 2006
House amendment agreed to: On agreeing to the Waxman amendment (A061) Agreed to by voice vote.
June 28, 2006 • 8:33 PM
Amendment agreed to Committee of the Whole
June 28, 2006 • 8:33 PM
House amendment offered/reported by : Amendment (A061) offered by Mr. Waxman.(consideration: CR H4762; text: CR H4762)
June 28, 2006 • 8:28 PM
Amendment (A061) offered by Mr. Waxman. (consideration: CR H4762; text: CR H4762)
June 28, 2006 • 8:28 PM
On agreeing to the Waxman amendment (A061) Agreed to by voice vote.
June 28, 2006 • 8:33 PM